Target of rapamycin inhibitors (TOR‐I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients

D Hahn, EM Hodson, LA Hamiwka… - Cochrane Database …, 2019 - cochranelibrary.com
Background Kidney transplantation is the therapy of choice for many patients with end‐stage
kidney disease (ESKD) with an improvement in survival rates and satisfactory short term …

Mammalian target of rapamycin inhibitors combined with calcineurin inhibitors as initial immunosuppression in renal transplantation: a meta-analysis

N Montero, M Quero, E Melilli, MJ Pérez-Sáez… - …, 2019 - journals.lww.com
Background. The current standard of care immunosuppressive regimen in kidney
transplantation (KT) includes a combination of mycophenolates (MMF/MPA) with a …